CR10709A - Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas - Google Patents
Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismasInfo
- Publication number
- CR10709A CR10709A CR10709A CR10709A CR10709A CR 10709 A CR10709 A CR 10709A CR 10709 A CR10709 A CR 10709A CR 10709 A CR10709 A CR 10709A CR 10709 A CR10709 A CR 10709A
- Authority
- CR
- Costa Rica
- Prior art keywords
- amidas
- elaboration
- same
- certain substituted
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84383306P | 2006-09-11 | 2006-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR10709A true CR10709A (es) | 2009-07-14 |
Family
ID=39184519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10709A CR10709A (es) | 2006-09-11 | 2009-04-03 | Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP2079726B1 (es) |
| JP (1) | JP5563301B2 (es) |
| KR (1) | KR101444481B1 (es) |
| CN (1) | CN101605778A (es) |
| AR (1) | AR063707A1 (es) |
| AT (1) | ATE496909T1 (es) |
| AU (1) | AU2007296563B2 (es) |
| BR (1) | BRPI0716914A2 (es) |
| CA (1) | CA2661951C (es) |
| CL (1) | CL2007002642A1 (es) |
| CO (1) | CO6180464A2 (es) |
| CR (1) | CR10709A (es) |
| DE (1) | DE602007012281D1 (es) |
| EC (1) | ECSP099238A (es) |
| ES (1) | ES2363269T3 (es) |
| IL (1) | IL197264A0 (es) |
| MA (1) | MA31276B1 (es) |
| MX (1) | MX2009002651A (es) |
| NO (1) | NO20091426L (es) |
| PE (1) | PE20081370A1 (es) |
| RU (1) | RU2009113692A (es) |
| TW (1) | TWI398439B (es) |
| WO (1) | WO2008033857A2 (es) |
| ZA (1) | ZA200901634B (es) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR063706A1 (es) * | 2006-09-11 | 2009-02-11 | Cgi Pharmaceuticals Inc | Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden. |
| CA2701275C (en) * | 2007-10-23 | 2016-06-21 | F. Hoffmann-La Roche Ag | Kinase inhibitors |
| US7683064B2 (en) | 2008-02-05 | 2010-03-23 | Roche Palo Alto Llc | Inhibitors of Bruton's tyrosine kinase |
| ES2554615T3 (es) * | 2008-05-06 | 2015-12-22 | Gilead Connecticut, Inc. | Amidas sustituidas, método de preparación y utilización como inhibidores de Btk |
| MX2010013191A (es) | 2008-06-24 | 2010-12-17 | Hoffmann La Roche | Nuevas piridin-3-onas y piridazin-3-onas sustituidas. |
| RU2507202C2 (ru) | 2008-07-02 | 2014-02-20 | Ф.Хоффманн-Ля Рош Аг | Новые фенилпиразиноны в качестве ингибиторов киназы |
| US8299077B2 (en) | 2009-03-02 | 2012-10-30 | Roche Palo Alto Llc | Inhibitors of Bruton's tyrosine kinase |
| AR082590A1 (es) | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
| MX2015001081A (es) | 2012-07-24 | 2015-10-14 | Pharmacyclics Inc | Mutaciones asociadas a resistencia a inhibidores de la tirosina cinasa de bruton (btk). |
| AU2014256633B2 (en) | 2013-04-25 | 2017-02-02 | Beone Medicines I Gmbh | Fused heterocyclic compounds as protein kinase inhibitors |
| CN104177338B (zh) * | 2013-05-22 | 2018-04-03 | 南京勇山生物科技有限公司 | 一类布鲁顿激酶抑制剂 |
| WO2015035606A1 (en) | 2013-09-13 | 2015-03-19 | Beigene, Ltd. | Anti-pd1 antibodies and their use as therapeutics and diagnostics |
| JP6275846B2 (ja) * | 2013-12-05 | 2018-02-07 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 求電子性官能基を有するヘテロアリールピリドン及びアザ−ピリドン化合物 |
| CN106604742B (zh) | 2014-07-03 | 2019-01-11 | 百济神州有限公司 | 抗pd-l1抗体及其作为治疗剂及诊断剂的用途 |
| WO2016079669A1 (en) * | 2014-11-19 | 2016-05-26 | Novartis Ag | Labeled amino pyrimidine derivatives |
| ES2928164T3 (es) | 2015-10-19 | 2022-11-15 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| ES2928856T3 (es) | 2015-11-19 | 2022-11-23 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| TW201726623A (zh) * | 2015-12-17 | 2017-08-01 | 英塞特公司 | 作為免疫調節劑之雜環化合物 |
| EP3394033B1 (en) | 2015-12-22 | 2020-11-25 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| ES2906460T3 (es) | 2016-05-06 | 2022-04-18 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| EP3464279B1 (en) | 2016-05-26 | 2021-11-24 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| KR20210019607A (ko) | 2016-06-07 | 2021-02-22 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| CA3028685A1 (en) | 2016-06-20 | 2017-12-28 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| JP6993056B2 (ja) | 2016-07-05 | 2022-02-15 | ベイジーン リミテッド | 癌治療のためのｐｄ－１アンタゴニスト及びｒａｆ阻害剤の組合せ |
| WO2018013789A1 (en) | 2016-07-14 | 2018-01-18 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| EP4353322A3 (en) | 2016-08-16 | 2024-07-31 | BeiGene Switzerland GmbH | Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof |
| US11701357B2 (en) | 2016-08-19 | 2023-07-18 | Beigene Switzerland Gmbh | Treatment of B cell cancers using a combination comprising Btk inhibitors |
| WO2018044783A1 (en) | 2016-08-29 | 2018-03-08 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| MA46285A (fr) | 2016-09-19 | 2019-07-31 | Mei Pharma Inc | Polythérapie |
| PE20191532A1 (es) | 2016-12-22 | 2019-10-23 | Incyte Corp | Compuestos heterociclicos como inmunomoduladores |
| ES2874756T3 (es) | 2016-12-22 | 2021-11-05 | Incyte Corp | Derivados de triazolo[1,5-A]piridina como inmunomoduladores |
| EP3558973B1 (en) | 2016-12-22 | 2021-09-15 | Incyte Corporation | Pyridine derivatives as immunomodulators |
| TW201835049A (zh) | 2016-12-22 | 2018-10-01 | 美商英塞特公司 | 作為免疫調節劑之雜環化合物 |
| MX391980B (es) | 2016-12-22 | 2025-03-21 | Incyte Corp | Derivados de tetrahidro imidazo [4,5-c] piridina como inductores de internalización de ligando 1 de muerte programada (pd-l1). |
| TWI774726B (zh) | 2017-01-25 | 2022-08-21 | 英屬開曼群島商百濟神州有限公司 | (S)-7-(1-(丁-2-炔醯基)哌啶-4-基)-2-(4-苯氧基苯基)-4,5,6,7-四氫吡唑并[1,5-a]嘧啶-3-甲醯胺的晶型、及其製備和用途 |
| NZ758458A (en) | 2017-03-23 | 2022-07-29 | Jacobio Pharmaceuticals Co Ltd | Novel heterocyclic derivatives useful as shp2 inhibitors |
| TWI877099B (zh) | 2017-06-26 | 2025-03-21 | 英屬開曼群島商百濟神州有限公司 | 抗ｐｄ－１抗體或其抗原結合片段在製備治療用於患有肝細胞癌（ｈｃｃ）之藥物的用途 |
| WO2019034009A1 (en) | 2017-08-12 | 2019-02-21 | Beigene, Ltd. | BTK INHIBITOR WITH ENHANCED DOUBLE SELECTIVITY |
| CN111801334B (zh) | 2017-11-29 | 2023-06-09 | 百济神州瑞士有限责任公司 | 使用包含btk抑制剂的组合治疗惰性或侵袭性b-细胞淋巴瘤 |
| IL313101A (en) | 2018-03-30 | 2024-07-01 | Incyte Corp | Heterocyclic compounds as immunomodulators |
| MD3790877T2 (ro) | 2018-05-11 | 2023-08-31 | Incyte Corp | Derivați de tetrahidro-imidazo[4,5-c]piridină în calitate de imunomodulatori PD-L1 |
| US20210393623A1 (en) | 2018-09-26 | 2021-12-23 | Jacobio Pharmaceuticals Co., Ltd. | Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors |
| TW202446397A (zh) | 2019-06-10 | 2024-12-01 | 瑞士商百濟神州瑞士有限責任公司 | 一種含有布魯頓氏酪胺酸激酶抑制劑的口服固體錠劑及其製備方法 |
| TW202115059A (zh) | 2019-08-09 | 2021-04-16 | 美商英塞特公司 | Ｐｄ—１／ｐｄ—ｌ１抑制劑之鹽 |
| JP7559059B2 (ja) | 2019-09-30 | 2024-10-01 | インサイト・コーポレイション | 免疫調節剤としてのピリド［３，２－ｄ］ピリミジン化合物 |
| WO2021096849A1 (en) | 2019-11-11 | 2021-05-20 | Incyte Corporation | Salts and crystalline forms of a pd-1/pd-l1 inhibitor |
| US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
| JP2023548859A (ja) | 2020-11-06 | 2023-11-21 | インサイト・コーポレイション | Ｐｄ－１／ｐｄ－ｌ１阻害剤ならびにその塩及び結晶形態を作製するためのプロセス |
| TW202233615A (zh) | 2020-11-06 | 2022-09-01 | 美商英塞特公司 | Ｐｄ—１／ｐｄ—ｌ１抑制劑之結晶形式 |
| US11786531B1 (en) | 2022-06-08 | 2023-10-17 | Beigene Switzerland Gmbh | Methods of treating B-cell proliferative disorder |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000043373A2 (en) * | 1999-01-22 | 2000-07-27 | Amgen Inc. | Kinase inhibitors |
| JP2005255675A (ja) * | 2004-02-09 | 2005-09-22 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| US8101770B2 (en) * | 2004-12-16 | 2012-01-24 | Vertex Pharmaceuticals Incorporated | Pyridones useful as inhibitors of kinases |
-
2007
- 2007-09-10 AR ARP070103989A patent/AR063707A1/es unknown
- 2007-09-10 PE PE2007001210A patent/PE20081370A1/es not_active Application Discontinuation
- 2007-09-11 CN CNA200780041899XA patent/CN101605778A/zh active Pending
- 2007-09-11 KR KR1020097007473A patent/KR101444481B1/ko not_active Expired - Fee Related
- 2007-09-11 CL CL200702642A patent/CL2007002642A1/es unknown
- 2007-09-11 WO PCT/US2007/078185 patent/WO2008033857A2/en not_active Ceased
- 2007-09-11 CA CA2661951A patent/CA2661951C/en not_active Expired - Fee Related
- 2007-09-11 ES ES07842267T patent/ES2363269T3/es active Active
- 2007-09-11 BR BRPI0716914-0A patent/BRPI0716914A2/pt not_active Application Discontinuation
- 2007-09-11 TW TW096133935A patent/TWI398439B/zh not_active IP Right Cessation
- 2007-09-11 JP JP2009527626A patent/JP5563301B2/ja active Active
- 2007-09-11 DE DE602007012281T patent/DE602007012281D1/de active Active
- 2007-09-11 AU AU2007296563A patent/AU2007296563B2/en not_active Ceased
- 2007-09-11 AT AT07842267T patent/ATE496909T1/de not_active IP Right Cessation
- 2007-09-11 RU RU2009113692/04A patent/RU2009113692A/ru not_active Application Discontinuation
- 2007-09-11 EP EP07842267A patent/EP2079726B1/en active Active
- 2007-09-11 MX MX2009002651A patent/MX2009002651A/es not_active Application Discontinuation
-
2009
- 2009-02-26 IL IL197264A patent/IL197264A0/en unknown
- 2009-03-06 ZA ZA200901634A patent/ZA200901634B/xx unknown
- 2009-04-01 CO CO09033749A patent/CO6180464A2/es not_active Application Discontinuation
- 2009-04-03 CR CR10709A patent/CR10709A/es unknown
- 2009-04-06 MA MA31767A patent/MA31276B1/fr unknown
- 2009-04-07 EC EC2009009238A patent/ECSP099238A/es unknown
- 2009-04-07 NO NO20091426A patent/NO20091426L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008033857A2 (en) | 2008-03-20 |
| CA2661951C (en) | 2014-11-18 |
| WO2008033857A3 (en) | 2008-06-05 |
| AU2007296563B2 (en) | 2013-01-10 |
| AU2007296563A1 (en) | 2008-03-20 |
| ATE496909T1 (de) | 2011-02-15 |
| ES2363269T3 (es) | 2011-07-28 |
| KR101444481B1 (ko) | 2014-09-24 |
| NO20091426L (no) | 2009-06-10 |
| CO6180464A2 (es) | 2010-07-19 |
| EP2079726A2 (en) | 2009-07-22 |
| CN101605778A (zh) | 2009-12-16 |
| AR063707A1 (es) | 2009-02-11 |
| BRPI0716914A2 (pt) | 2013-11-05 |
| MA31276B1 (fr) | 2010-04-01 |
| ZA200901634B (en) | 2009-12-30 |
| KR20090074192A (ko) | 2009-07-06 |
| JP5563301B2 (ja) | 2014-07-30 |
| TWI398439B (zh) | 2013-06-11 |
| CA2661951A1 (en) | 2008-03-20 |
| PE20081370A1 (es) | 2008-11-28 |
| CL2007002642A1 (es) | 2008-07-18 |
| ECSP099238A (es) | 2009-07-31 |
| MX2009002651A (es) | 2009-03-26 |
| DE602007012281D1 (de) | 2011-03-10 |
| TW200829567A (en) | 2008-07-16 |
| RU2009113692A (ru) | 2010-10-20 |
| JP2010502750A (ja) | 2010-01-28 |
| IL197264A0 (en) | 2009-12-24 |
| EP2079726B1 (en) | 2011-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR10709A (es) | Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas | |
| CR10743A (es) | Derivados de azaadamantano y metodos de uso de los mismos | |
| BRPI0811635A2 (pt) | Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos | |
| BRPI0718543A2 (pt) | Dispositivos oculares e métodos de fabricação e uso dos mesmos | |
| EP1943080A4 (en) | METHOD AND APPARATUS FOR BLOW MOLDING WITH STRETCHING | |
| EP1731506A4 (en) | 5-HYDROXYINDOL-3-CARBOXYLATE DERIVATIVES AND THEIR USE | |
| MA29039B1 (fr) | Dibenzylamines et derives | |
| DE602006010464D1 (de) | Punktsuchvorrichtung und Suchverfahren | |
| BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
| BRPI0714793A2 (pt) | Análogos de niacina não enrubecedores e método de uso dos mesmos. | |
| HRP20220755T3 (hr) | Anti-gm-csf antitijela i njihova uporaba | |
| FI20080423L (fi) | Biologisten komponenttien rikastusyksikkö ja rikastusmenetelmä | |
| BRPI0716327A2 (pt) | Composto de fenilpropionamida e uso | |
| CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
| BRPI0812909A2 (pt) | Derivados de guanina policíclica e métodos de uso dos mesmos. | |
| EP1848377A4 (en) | APPARATUS AND METHOD FOR ARTHROPLASTY OF THE SHOULDER | |
| FI20045322L (fi) | Kuivain sekä menetelmä sen käyttämiseksi ja valmistamiseksi | |
| DE602006017463D1 (de) | Navigationssystem und -verfahren | |
| DE602006011600D1 (de) | Audiocodierungseinrichtung und audiocodierungsverfahren | |
| EP1732707A4 (en) | ACTIVATION METHOD | |
| BRPI0720323A2 (pt) | composto, método de tratamento, composição farmacêutica e uso do composto | |
| DE602006014957D1 (de) | Audiocodierungseinrichtung und audiocodierungsverfahren | |
| PT1763520E (pt) | Utilização de benzopiranonas trissubstituídas | |
| EP1961753A4 (en) | PYRAZOLOPYRIMIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR USE | |
| FI20060029L (fi) | Mittausjärjestelmä, mittausmenetelmä ja antennin uusi käyttö |